Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$23,894
+$5,806 QoQ
Shares Held
350
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#252
of 373 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Strategic Wealth Partners, Ltd. holds $1,074,683 across 10 Diagnostics & Research names. GRAL ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,490 | $747,026 | |
| 2 | DHR |
Danaher Corp /De/
|
897 | $170,860 | |
| 3 | DGX |
Quest Diagnostics Inc
|
248 | $52,563 | |
| 4 | ICLR |
Icon PLC
|
170 | $29,530 | |
| 5 | GRAL |
GRAIL, Inc.
This page
|
350 | $23,894 | |
| 6 | LH |
Labcorp Holdings Inc.
|
66 | $18,480 | |
| 7 | A |
Agilent Technologies, Inc.
|
132 | $17,533 | |
| 8 | NTRA |
Natera, Inc.
|
50 | $13,572 |
All Filings in GRAL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,894 | 350 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $18,088 | 350 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $29,956 | 350 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $2,956 | 50 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||